ELV Elevance Health
Intrinsic value$281.98
Price (at call)$405.84
Margin of safety
-30.5%
vs market (rating basis)
+29.1%
Model unavailable; showing baseline valuation.
⚠ LLM error: empty response; using baseline
The story
Value drivers
| Revenue growth (Y1) | 8.3% |
| Terminal growth | 3.5% |
| Forecast horizon | 10y |
| Target operating margin | 3.6% |
| Years to target margin | 5 |
| Sales-to-capital | 2.65 |
| Beta | 0.69 |
| Failure probability | 0.0% |
| Cost of capital (WACC) | 7.4% |
| Terminal WACC | 8.4% |
Valuation bridge
| PV of explicit FCFF | 18.18B |
| PV of terminal value | 65.67B |
| Equity value | 61.15B |
| ÷ shares → per share | $281.98 |
News
neutral +0.15 · 8 articles
- Centene Stock Roars Back 117% in a Year: Is CNC Still a Buy?
- How Is Elevance Health’s Stock Performance Compared to Other Health Providers?
- Can Centene's Marketplace Recovery Fuel Stronger Earnings Growth?
- Elevance Health (ELV) Soars as Investors Gain Confidence in Profitability
- Elevance Health (ELV): Bridging the Gap between Care and Coverage
- UNH Stock Gets Cheaper Only If The Margins Come Back
- Is CVS Stock Set for a Rebound?
- Health Insurance Providers Stocks Q2 In Review: Elevance Health (NYSE:ELV) Vs Peers
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 217.88B | 8.3% | 3.6% | 6.67B | 6.33B | 341.09M | 317.55M |
| 2 | 234.88B | 7.8% | 3.6% | 7.19B | 6.42B | 775.89M | 672.49M |
| 3 | 251.94B | 7.3% | 3.6% | 7.72B | 6.44B | 1.27B | 1.03B |
| 4 | 268.88B | 6.7% | 3.6% | 8.23B | 6.40B | 1.84B | 1.38B |
| 5 | 285.52B | 6.2% | 3.6% | 8.74B | 6.28B | 2.46B | 1.72B |
| 6 | 301.66B | 5.7% | 3.6% | 9.24B | 6.09B | 3.15B | 2.05B |
| 7 | 317.08B | 5.1% | 3.6% | 9.71B | 5.82B | 3.89B | 2.36B |
| 8 | 331.59B | 4.6% | 3.6% | 10.15B | 5.48B | 4.68B | 2.64B |
| 9 | 344.97B | 4.0% | 3.6% | 10.56B | 5.05B | 5.51B | 2.89B |
| 10 | 357.05B | 3.5% | 3.6% | 10.93B | 4.56B | 6.38B | 3.12B |